1: Mirza SB, Lee RCH, Chu JJH, Salmas RE, Mavromoustakos T, Durdagi S. Discovery of selective dengue virus inhibitors using combination of molecular fingerprint-based virtual screening protocols, structure-based pharmacophore model development, molecular dynamics simulations and in vitro studies. J Mol Graph Model. 2018 Jan;79:88-102. doi: 10.1016/j.jmgm.2017.10.010. Epub 2017 Oct 24. PubMed PMID: 29156382.
2: Mirza SB, Lee RCH, Chu JJH, Salmas RE, Mavromoustakos T, Durdagi S. Discovery of selective dengue virus inhibitors using combination of molecular fingerprint-based virtual screening protocols, structure-based pharmacophore model development, molecular dynamics simulations and in vitro studies. J Mol Graph Model. 2017 Aug 9;77:338. doi: 10.1016/j.jmgm.2017.08.006. [Epub ahead of print] PubMed PMID: 28957754.
3: Oyer JL, Pandey V, Igarashi RY, Somanchi SS, Zakari A, Solh M, Lee DA, Altomare DA, Copik AJ. Natural killer cells stimulated with PM21 particles expand and biodistribute in vivo: Clinical implications for cancer treatment. Cytotherapy. 2016 May;18(5):653-63. doi: 10.1016/j.jcyt.2016.02.006. PubMed PMID: 27059202.
4: Raut R, Beesetti H, Tyagi P, Khanna I, Jain SK, Jeankumar VU, Yogeeswari P, Sriram D, Swaminathan S. A small molecule inhibitor of dengue virus type 2 protease inhibits the replication of all four dengue virus serotypes in cell culture. Virol J. 2015 Feb 8;12:16. doi: 10.1186/s12985-015-0248-x. PubMed PMID: 25886260; PubMed Central PMCID: PMC4327787.
5: Solanki MK, Singh RK, Srivastava S, Kumar S, Kashyap PL, Srivastava AK, Arora DK. Isolation and characterization of siderophore producing antagonistic rhizobacteria against Rhizoctonia solani. J Basic Microbiol. 2014 Jun;54(6):585-97. doi: 10.1002/jobm.201200564. Epub 2013 May 20. PubMed PMID: 23686438.
6: Küçük C, Iqbal J, Hu X, Gaulard P, De Leval L, Srivastava G, Au WY, McKeithan TW, Chan WC. PRDM1 is a tumor suppressor gene in natural killer cell malignancies. Proc Natl Acad Sci U S A. 2011 Dec 13;108(50):20119-24. doi: 10.1073/pnas.1115128108. Epub 2011 Dec 5. PubMed PMID: 22143801; PubMed Central PMCID: PMC3250125.
7: Guo WX, Pye QN, Williamson KS, Stewart CA, Hensley KL, Kotake Y, Floyd RA, Broyles RH. Mitochondrial dysfunction in choline deficiency-induced apoptosis in cultured rat hepatocytes. Free Radic Biol Med. 2005 Sep 1;39(5):641-50. PubMed PMID: 16085182.
8: Bitsch M, Saunte DM, Lohmann M, Holstein PE, Jørgensen B, Gottrup F. Standardised method of surgical treatment of chronic leg ulcers. Scand J Plast Reconstr Surg Hand Surg. 2005;39(3):162-9. PubMed PMID: 16019749.
9: Bom IJ, Klis FM, de Nobel H, Brul S. A new strategy for inhibition of the spoilage yeasts Saccharomyces cerevisiae and Zygosaccharomyces bailii based on combination of a membrane-active peptide with an oligosaccharide that leads to an impaired glycosylphosphatidylinositol (GPI)-dependent yeast wall protein layer. FEMS Yeast Res. 2001 Dec;1(3):187-94. PubMed PMID: 12702343.
10: Shepherd CM, Vogel HJ, Tieleman DP. Interactions of the designed antimicrobial peptide MB21 and truncated dermaseptin S3 with lipid bilayers: molecular-dynamics simulations. Biochem J. 2003 Feb 15;370(Pt 1):233-43. PubMed PMID: 12423203; PubMed Central PMCID: PMC1223151.
11: Moll GN, Brul S, Konings WN, Driessen AJ. Comparison of the membrane interaction and permeabilization by the designed peptide Ac-MB21-NH2 and truncated dermaseptin S3. Biochemistry. 2000 Oct 3;39(39):11907-12. PubMed PMID: 11009603.
12: ter Steeg PF, Hellemons JC, Kok AE. Synergistic actions of nisin, sublethal ultrahigh pressure, and reduced temperature on bacteria and yeast. Appl Environ Microbiol. 1999 Sep;65(9):4148-54. PubMed PMID: 10473428; PubMed Central PMCID: PMC99753.
13: Sherman MI. Long term culture of cells derived from mouse blastocysts. Differentiation. 1975 Aug 11;3(1-3):51-67. PubMed PMID: 1183760.